Bank Of America Corp Bio Xcel Therapeutics, Inc. Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 52,952 shares of BTAI stock, worth $122,319. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,952
Previous 83,701
36.74%
Holding current value
$122,319
Previous $51,000
62.75%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding BTAI
# of Institutions
51Shares Held
8.69MCall Options Held
22.2KPut Options Held
27.7K-
Armistice Capital, LLC New York, NY4.32MShares$9.97 Million0.02% of portfolio
-
Ubs Group Ag1.28MShares$2.95 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.19MShares$2.74 Million0.0% of portfolio
-
Black Rock Inc. New York, NY441KShares$1.02 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA312KShares$720,6390.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $64.7M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...